Moderna (MRNA) Change in Taxes (2021 - 2024)

Moderna has reported Change in Taxes for 4 years, with the latest figure at -$2.0 million in Q3 2024.

• Change in Taxes for Q3 2024 came in at -$2.0 million, down 122.22% year-over-year; the trailing twelve-month figure through Sep 2024 was -$51.0 million (down 410.0% YoY), and the FY2023 annual result was $15.0 million, up 101.81% from the prior year.
• Change in Taxes climbed to -$2.0 million in Q3 2024, from -$45.0 million in the prior quarter.
• Over five years, Change in Taxes peaked at $716.0 million in Q1 2022 and troughed at -$1.2 billion in Q2 2022.
• A 4-year average of $333333.3 and a median of $7.0 million in 2023 frame the typical range for Change in Taxes.
• The largest YoY upside for Change in Taxes was 695.56% in 2022 against a maximum downside of 533.1% in 2022.
• A 4-year view of Change in Taxes shows it stood at $311.0 million in 2021, then sank by 105.79% to -$18.0 million in 2022, then soared by 138.89% to $7.0 million in 2023, then plunged by 128.57% to -$2.0 million in 2024.
• Per Business Quant data, the three most recent Change in Taxes figures were -$2.0 million in Q3 2024, -$45.0 million in Q2 2024, and -$11.0 million in Q1 2024.